Trial
NCT00366795
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Sanofi
Collaborators
—
Condition
Ascites
Intervention
Satavaptan
Why stopped
Study was terminated due to safety reason.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-18